Article
Variable virological outcomes according to the center providing antiretroviral therapy within the PharmAdapt clinical trial.
HIV clinical trials - 1 Jan 2000
Clevenbergh P, Bozonnat M C, Kirstetter M, Durant J, Cua E, del Giudice P, Montagne N, Simonet P
Abstract excerpt
PURPOSE: Differences in virological response between HIV-infected patients at different study centers were analyzed as a substudy of PharmAdapt, a multicenter prospective randomized study to evaluate the utility of therapeutic drug monitoring after a genotypic-based treatment adaptation. RESULTS: After 12 weeks, the percentage of patients participating in PharmAdapt with HIV RNA < 200 copies/mL ranged from 17% to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.